BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 11737865)

  • 1. Peroxisome proliferator-activated receptor agonists prevent 25-OH-cholesterol induced c-jun activation and cell death.
    Chang JY; Liu LZ
    BMC Pharmacol; 2001; 1():10. PubMed ID: 11737865
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endothelin-1-induced cardiac hypertrophy is inhibited by activation of peroxisome proliferator-activated receptor-alpha partly via blockade of c-Jun NH2-terminal kinase pathway.
    Irukayama-Tomobe Y; Miyauchi T; Sakai S; Kasuya Y; Ogata T; Takanashi M; Iemitsu M; Sudo T; Goto K; Yamaguchi I
    Circulation; 2004 Feb; 109(7):904-10. PubMed ID: 14967736
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective inhibition of cyclooxygenase-2 expression by 15-deoxy-Delta(12,14)(12,14)-prostaglandin J(2) in activated human astrocytes, but not in human brain macrophages.
    Janabi N
    J Immunol; 2002 May; 168(9):4747-55. PubMed ID: 11971025
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Indomethacin induces apoptosis in 786-O renal cell carcinoma cells by activating mitogen-activated protein kinases and AKT.
    Ou YC; Yang CR; Cheng CL; Raung SL; Hung YY; Chen CJ
    Eur J Pharmacol; 2007 Jun; 563(1-3):49-60. PubMed ID: 17341418
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ligands for the peroxisome proliferator-activated receptor-gamma and the retinoid X receptor exert additive anti-inflammatory effects on experimental autoimmune encephalomyelitis.
    Diab A; Hussain RZ; Lovett-Racke AE; Chavis JA; Drew PD; Racke MK
    J Neuroimmunol; 2004 Mar; 148(1-2):116-26. PubMed ID: 14975592
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effects of peroxisome proliferator-activated receptor-gamma agonist on Fas-mediated apoptosis in HT-29 cells].
    Chung YW; Han DS; Kang EK; Lee JS; Lee HR; Kim JB; Park JY; Kim YS; Lee OY; Choi HS; Sohn JH; Yoo DH; Hahm JS
    Korean J Gastroenterol; 2003 Jul; 42(1):35-41. PubMed ID: 14532729
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peroxisome proliferator activator receptor-gamma agonists and 15-deoxy-Delta(12,14)(12,14)-PGJ(2) induce apoptosis in normal and malignant B-lineage cells.
    Padilla J; Kaur K; Cao HJ; Smith TJ; Phipps RP
    J Immunol; 2000 Dec; 165(12):6941-8. PubMed ID: 11120820
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PPAR agonists protect mesangial cells from interleukin 1beta-induced intracellular lipid accumulation by activating the ABCA1 cholesterol efflux pathway.
    Ruan XZ; Moorhead JF; Fernando R; Wheeler DC; Powis SH; Varghese Z
    J Am Soc Nephrol; 2003 Mar; 14(3):593-600. PubMed ID: 12595494
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rosiglitazone and 15-deoxy-Delta12,14-prostaglandin J2, ligands of the peroxisome proliferator-activated receptor-gamma (PPAR-gamma), reduce ischaemia/reperfusion injury of the gut.
    Cuzzocrea S; Pisano B; Dugo L; Ianaro A; Patel NS; Di Paola R; Genovese T; Chatterjee PK; Di Rosa M; Caputi AP; Thiemermann C
    Br J Pharmacol; 2003 Sep; 140(2):366-76. PubMed ID: 12970094
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 15-deoxy-delta12,14-prostaglandin J2 regulates the functional state and the survival of microglial cells through multiple molecular mechanisms.
    Bernardo A; Ajmone-Cat MA; Levi G; Minghetti L
    J Neurochem; 2003 Nov; 87(3):742-51. PubMed ID: 14535956
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peroxisome proliferator-activated receptor-gamma agonist 15-deoxy-Delta(12,14)-prostaglandin J(2) ameliorates experimental autoimmune encephalomyelitis.
    Diab A; Deng C; Smith JD; Hussain RZ; Phanavanh B; Lovett-Racke AE; Drew PD; Racke MK
    J Immunol; 2002 Mar; 168(5):2508-15. PubMed ID: 11859145
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuroprotective effects of PPARgamma agonists against oxidative insults in HT-22 cells.
    Aoun P; Watson DG; Simpkins JW
    Eur J Pharmacol; 2003 Jul; 472(1-2):65-71. PubMed ID: 12860474
    [TBL] [Abstract][Full Text] [Related]  

  • 13. C-Jun N-terminal kinases/c-Jun and p38 pathways cooperate in ceramide-induced neuronal apoptosis.
    Willaime-Morawek S; Brami-Cherrier K; Mariani J; Caboche J; Brugg B
    Neuroscience; 2003; 119(2):387-97. PubMed ID: 12770554
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of the peroxisome proliferator-activated receptor-gamma (PPAR-gamma) and its natural ligand 15-deoxy-Delta12, 14-prostaglandin J2 in the regulation of microglial functions.
    Bernardo A; Levi G; Minghetti L
    Eur J Neurosci; 2000 Jul; 12(7):2215-23. PubMed ID: 10947800
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peroxisome proliferator--activated receptor gamma activators inhibit interleukin-1beta-induced nitric oxide and matrix metalloproteinase 13 production in human chondrocytes.
    Fahmi H; Di Battista JA; Pelletier JP; Mineau F; Ranger P; Martel-Pelletier J
    Arthritis Rheum; 2001 Mar; 44(3):595-607. PubMed ID: 11263774
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cholesterol oxides induce programmed cell death in microglial cells.
    Chang JY; Chavis JA; Liu LZ; Drew PD
    Biochem Biophys Res Commun; 1998 Aug; 249(3):817-21. PubMed ID: 9731219
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuronal differentiation of embryonic midbrain cells by upregulation of peroxisome proliferator-activated receptor-gamma via the JNK-dependent pathway.
    Park KS; Lee RD; Kang SK; Han SY; Park KL; Yang KH; Song YS; Park HJ; Lee YM; Yun YP; Oh KW; Kim DJ; Yun YW; Hwang SJ; Lee SE; Hong JT
    Exp Cell Res; 2004 Jul; 297(2):424-33. PubMed ID: 15212945
    [TBL] [Abstract][Full Text] [Related]  

  • 18. c-Jun N-terminal kinases (JNKs) mediate pro-inflammatory actions of microglia.
    Waetzig V; Czeloth K; Hidding U; Mielke K; Kanzow M; Brecht S; Goetz M; Lucius R; Herdegen T; Hanisch UK
    Glia; 2005 May; 50(3):235-46. PubMed ID: 15739188
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Superoxide anion-dependent Raf/MEK/ERK activation by peroxisome proliferator activated receptor gamma agonists 15-deoxy-delta(12,14)-prostaglandin J(2), ciglitazone, and GW1929.
    Huang WC; Chio CC; Chi KH; Wu HM; Lin WW
    Exp Cell Res; 2002 Jul; 277(2):192-200. PubMed ID: 12083801
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ligands of the peroxisome proliferator-activated receptors (PPAR-gamma and PPAR-alpha) reduce myocardial infarct size.
    Wayman NS; Hattori Y; McDonald MC; Mota-Filipe H; Cuzzocrea S; Pisano B; Chatterjee PK; Thiemermann C
    FASEB J; 2002 Jul; 16(9):1027-40. PubMed ID: 12087064
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.